How much weight a person loses on GLP-1 agonists depends on many factors, including genetics and how they respond to the drugs
The results suggest that biweekly dosing with bofanglutide can produce HbA1c reductions comparable to weekly semaglutide, with the trade-off of somewhat higher gastrointestinal side effect frequency, particularly early in treatment
These mechanisms not only support blood sugar management but also facilitate weight loss, making GLP-1 receptor agonists a dual-action solution for many patients
So, its a very bad outcome when it happens
She had not wanted to take the shortcut, she said on Oprah Winfreys podcast last August, but, Williams said, getting to where she wanted to be after her two pregnancies was not working through training alone